Companies Directory

Halim Mazmin Berhad is a hospitality company based out of Kuala Lumpur, Federal Territory of Kuala Lumpur, Malaysia.

Halina European Day Spa is an individual & family services company based out of 7720 Oconner Dr, Round Rock, Texas, United States.

HalioDx is an immuno-oncology diagnostic company providing oncologists and drug development organizations with first-in-class Immune-based diagnostic products and services to guide cancer care and contribute to precision medicine in the era of immuno-oncology and combination therapies. Leveraging the pioneering work of Dr Jérôme Galon, HalioDx provides a unique range of immune scoring solutions including its flagship Immunoscore® assay for the assessment of the immune contexture of a tumor, as a key determinant of patients’ outcomes and response to cancer treatments. HalioDx has developed a unique Biopharma partnering ecosystem for the identification of clinically relevant biomarker signatures, the demonstration of their clinical utility in trials and the development and commercialization of resulting diagnostic or companion diagnostic tests. Our programs draw on our expertise and focus on immuno-oncology, a complete suite of genomic and proteomic biomarker profiling services, a world-class data analysis and biostatistics platform, and CLIA-certified laboratories with compliant facilities in Europe and in the US to develop, manufacture, register and market in vitro diagnostic (IVD) products. HalioDx has rapidly become the preferred partner of Biopharma developing therapeutic antibodies, vaccines, chemotherapies, oncolytic peptides, and CAR-T cell therapies. About Immunoscore® Immunoscore® is an in vitro diagnostic test measuring the host immune response at the tumor site. It provides a robust, precise, quantitative, and consensus assessment of lymphocytic infiltration and has been shown to predict patient outcome and response to therapies in several indications. Immunoscore® was included in the 2020 European Society of Medical Oncology (ESMO) Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up for Localized Colon Cancer. Immunoscore® is commercially available in more than 20 countries.

HalioDx is an immuno-oncology diagnostic company providing oncologists and drug development organizations with first-in-class Immune-based diagnostic products and services to guide cancer care and contribute to precision medicine in the era of immuno-oncology and combination therapies. Leveraging the pioneering work of Dr Jérôme Galon, HalioDx provides a unique range of immune scoring solutions including its flagship Immunoscore® assay for the assessment of the immune contexture of a tumor, as a key determinant of patients’ outcomes and response to cancer treatments. HalioDx has developed a unique Biopharma partnering ecosystem for the identification of clinically relevant biomarker signatures, the demonstration of their clinical utility in trials and the development and commercialization of resulting diagnostic or companion diagnostic tests. Our programs draw on our expertise and focus on immuno-oncology, a complete suite of genomic and proteomic biomarker profiling services, a world-class data analysis and biostatistics platform, and CLIA-certified laboratories with compliant facilities in Europe and in the US to develop, manufacture, register and market in vitro diagnostic (IVD) products. HalioDx has rapidly become the preferred partner of Biopharma developing therapeutic antibodies, vaccines, chemotherapies, oncolytic peptides, and CAR-T cell therapies. About Immunoscore® Immunoscore® is an in vitro diagnostic test measuring the host immune response at the tumor site. It provides a robust, precise, quantitative, and consensus assessment of lymphocytic infiltration and has been shown to predict patient outcome and response to therapies in several indications. Immunoscore® was included in the 2020 European Society of Medical Oncology (ESMO) Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up for Localized Colon Cancer. Immunoscore® is commercially available in more than 20 countries.

HalioDx is an immuno-oncology diagnostic company providing oncologists and drug development organizations with first-in-class Immune-based diagnostic products and services to guide cancer care and contribute to precision medicine in the era of immuno-oncology and combination therapies. Leveraging the pioneering work of Dr Jérôme Galon, HalioDx provides a unique range of immune scoring solutions including its flagship Immunoscore® assay for the assessment of the immune contexture of a tumor, as a key determinant of patients’ outcomes and response to cancer treatments. HalioDx has developed a unique Biopharma partnering ecosystem for the identification of clinically relevant biomarker signatures, the demonstration of their clinical utility in trials and the development and commercialization of resulting diagnostic or companion diagnostic tests. Our programs draw on our expertise and focus on immuno-oncology, a complete suite of genomic and proteomic biomarker profiling services, a world-class data analysis and biostatistics platform, and CLIA-certified laboratories with compliant facilities in Europe and in the US to develop, manufacture, register and market in vitro diagnostic (IVD) products. HalioDx has rapidly become the preferred partner of Biopharma developing therapeutic antibodies, vaccines, chemotherapies, oncolytic peptides, and CAR-T cell therapies. About Immunoscore® Immunoscore® is an in vitro diagnostic test measuring the host immune response at the tumor site. It provides a robust, precise, quantitative, and consensus assessment of lymphocytic infiltration and has been shown to predict patient outcome and response to therapies in several indications. Immunoscore® was included in the 2020 European Society of Medical Oncology (ESMO) Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up for Localized Colon Cancer. Immunoscore® is commercially available in more than 20 countries.

HalioDx is an immuno-oncology diagnostic company providing oncologists and drug development organizations with first-in-class Immune-based diagnostic products and services to guide cancer care and contribute to precision medicine in the era of immuno-oncology and combination therapies. Leveraging the pioneering work of Dr Jérôme Galon, HalioDx provides a unique range of immune scoring solutions including its flagship Immunoscore® assay for the assessment of the immune contexture of a tumor, as a key determinant of patients’ outcomes and response to cancer treatments. HalioDx has developed a unique Biopharma partnering ecosystem for the identification of clinically relevant biomarker signatures, the demonstration of their clinical utility in trials and the development and commercialization of resulting diagnostic or companion diagnostic tests. Our programs draw on our expertise and focus on immuno-oncology, a complete suite of genomic and proteomic biomarker profiling services, a world-class data analysis and biostatistics platform, and CLIA-certified laboratories with compliant facilities in Europe and in the US to develop, manufacture, register and market in vitro diagnostic (IVD) products. HalioDx has rapidly become the preferred partner of Biopharma developing therapeutic antibodies, vaccines, chemotherapies, oncolytic peptides, and CAR-T cell therapies. About Immunoscore® Immunoscore® is an in vitro diagnostic test measuring the host immune response at the tumor site. It provides a robust, precise, quantitative, and consensus assessment of lymphocytic infiltration and has been shown to predict patient outcome and response to therapies in several indications. Immunoscore® was included in the 2020 European Society of Medical Oncology (ESMO) Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up for Localized Colon Cancer. Immunoscore® is commercially available in more than 20 countries.

A Halipar – Holding de Alimentação e Participações – abriga mais de 400 unidades franqueadas distribuídas em 24 estados brasileiros. Com a união de marcas voltadas a diferentes públicos, somos uma das maiores holdings do mercado nacional de franchising do ramo de alimentação. Ao longo dos últimos anos, nossas marcas conquistaram diversos prêmios, mostrando sua qualidade e comprometimento com os clientes, entre eles o prêmio de Melhor Franquia do Brasil pelo Serasa Experian. Em 2020, nossas marcas foram premiadas com 5 estrelas no Guia de Franquias da Revista Pequenas Empresas & Grandes Negócios (PEGN) Marcas do Grupo Halipar: - Griletto - Montana Grill - Jin Jin - Croasonho

Are you a tech savvy communication professional? Do you use events as a means of connection? Do your events contribute to strategic business objectives? Then we at Halito! are happy to be your buddies for a happy event flow! Manage any event in 5 easy steps: 1. Inform Build an event site in your own corporate identity 2. Invite Import a guest list and send an invitation via email 3. Register Create a smart registration form, let guests register and send them an automatic confirmation 4. Welcome Scan the QR code, guide VIPs and control access 5. Thank you Share photos, videos and presentations and hold a survey Halito! is a Software as a Service solution with numerous event software features: - event website - event invitation - visitor registration - online and hybrid events - workshops - paying events - on-site access control - event evaluation - integration via API - event tools and apps - user management - reports To complete the experience for your guests, Halito! integrations with numerous niche players in and for the event industry, but also beyond. That way, as an event manager, you can expand each event with the partners you really need. At Halito! security comes first. We can develop nice features, but if personal data is not stored and processed in a secure way, the software is of no use. Our principle is, therefore “Security by design”. Before using Halito! no technical knowledge is required, but if you still have questions, our friendly customer success managers are available daily for a personal answer via phone, e-mail and an online knowledge base with 175+ help articles.

İnsanların geleceğiyle ilgili finansal planlamalarında; etkili, güvenilir ve güçlü şirket: Halk Emeklilik Halk Emeklilk, 1998 yılında başladığı sigortacılık faaliyetlerini bugün Bireysel Emeklilik ve Hayat Sigortaları alanında başarıyla devam ettirmektedir. Vizyonumuz : İnsanların geleceğiyle ilgili finansal planlamalarında; etkili, güvenilir ve güçlü şirket olmak. İnsanların ve sevdiklerinin gelecekle ilgili finansal planlarını yapmalarına yardımcı olmak, gelecekle ilgili finansal çözümler üretmek, tasarruf bilincinin oluşturulmasına katkıda bulunmak, bu alanda saygın bir şirket olmak.

İnsanların geleceğiyle ilgili finansal planlamalarında; etkili, güvenilir ve güçlü şirket: Halk Emeklilik Halk Emeklilk, 1998 yılında başladığı sigortacılık faaliyetlerini bugün Bireysel Emeklilik ve Hayat Sigortaları alanında başarıyla devam ettirmektedir. Vizyonumuz : İnsanların geleceğiyle ilgili finansal planlamalarında; etkili, güvenilir ve güçlü şirket olmak. İnsanların ve sevdiklerinin gelecekle ilgili finansal planlarını yapmalarına yardımcı olmak, gelecekle ilgili finansal çözümler üretmek, tasarruf bilincinin oluşturulmasına katkıda bulunmak, bu alanda saygın bir şirket olmak.